ORMP - Oramed Pharmaceuticals, Inc
IEX Last Trade
2.385
-0.015 -0.629%
Share volume: 62,141
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.40
-0.02
-0.63%
Summary score
17%
Profitability
0%
Dept financing
12%
Liquidity
50%
Performance
27%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.55%
Return on assets
-8.13%
Return on sales
-617.32%
Return on invested capital
-33.01%
Total debt ratio
44.05%
Debt ratio change over timeo
-2.47%
Current Ratio
5.67%
Quick Ratio
0%
Cash Position Ratio
0.67%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.04%
Return on assets
-9.21%
Return on sales
-612.08%
Return on invested capital
-27.75%
Total debt ratio
39.91%
Debt ratio change over timeo
-1.92%
Current Ratio
6.07%
Quick Ratio
0%
Cash Position Ratio
0.75%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-11.76%
Return on assets
-6.77%
Return on sales
0%
Return on invested capital
57.45%
Total debt ratio
44.05%
Debt ratio change over time
-1.61%
Current Ratio
6.28%
Quick Ratio
0%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-51.98%
Return on assets
-72.78%
Return on sales
1612.66%
Return on invested capital
9.06%
Total debt ratio
-246.51%
Debt ratio change over time
-2.47%
Current Ratio
-17.43%
Quick Ratio
0%
Cash Position Ratio
-2.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORMP | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -14.55% | 10.78% | 20.46% | 4.09% |
| Return on assets | -8.13% | 3.26% | 11.82% | 3.42% |
| Return on sales | -617.32% | 23.28% | 42.55% | 26.47% |
| Return on invested capital | -33.01% | 4.09% | -313.95% | 4.02% |
| Profitability | 0% | 59% | 75% | 52% |
| Total debt ratio | 44.05% | 73.53% | 53.75% | 56.89% |
| Debt ratio change over time | -2.47% | -1.66% | -1.2% | 10.92% |
| Dept financing | 15% | 25% | 18% | 44% |
| Current Ratio | 6.07% | 1.29% | 1.02% | 1.38% |
| Quick Ratio | 0% | 1% | 0.73% | 1.09% |
| Cash Position Ratio | 0.75% | 0.3% | 0.25% | 0.54% |
| Liquididy | 50% | 39% | 32% | 55% |
| Short-term ratios | ORMP | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -15.04% | 29.72% | 19.04% | 5.92% |
| Return on assets | -9.21% | 3.64% | 10.97% | 3.4% |
| Return on sales | -612.08% | 25.5% | 42.41% | 25.5% |
| Return on invested capital | -27.75% | 8.1% | -59.59% | 4.48% |
| Profitability | 0% | 73% | 66% | 42% |
| Total debt ratio | 39.91% | 88.74% | 55.71% | 61.26% |
| Debt ratio change over time | -1.92% | 11.75% | -0.99% | 14% |
| Dept financing | 11% | 46% | 16% | 42% |
| Current Ratio | 6.07% | 1.29% | 1.02% | 1.38% |
| Quick Ratio | 0% | 1% | 0.73% | 1.09% |
| Cash Position Ratio | 0.75% | 0.3% | 0.25% | 0.54% |
| Liquididy | 50% | 38% | 29% | 49% |